$3.67
-0.53-12.54%
Last update: Nov 12, 11:33 AM
Starling Oncology Inc (STLN) Stock Price, Quote, News & History
STLNNASDAQ
Starling Oncology (NASDAQ:STLN) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Starling Oncology (NASDAQ:STLN) through any online brokerage.
Other companies in Starling Oncology’s space includes: HCA Healthcare Inc (NYSE:HCA), Tenet Healthcare Corp (NYSE:THC), Encompass Health Corp (NYSE:EHC), Universal Health Services Inc (NYSE:UHS) and Ensign Group Inc (NASDAQ:ENSG).
Starling Oncology has a consensus price target of $9.25.
The stock price for Starling Oncology (NASDAQ: STLN) is $3.6733 last updated November 12, 2026 at 11:33 AM EST.
There are no upcoming dividends for Starling Oncology.
Starling Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Starling Oncology.
Starling Oncology is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
